ROMANO KATHRYN — SEC Form 4 filings
SEC reporting owner CIK 1801385. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-24 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 35 legs across 7 filings — 37,087 shares, $7,240,798 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 59.
- Largest priced transaction: sale of 5,700 shares @ $271.66 ($1,548,477) in Krystal Biotech, Inc., filed 2026-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | 7 | — | 35 legs · 37,087 sh · $7,240,798 | 59 |
Form 4 filings — ROMANO KATHRYN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,262 @ $275.64 · Option exercise (M): 550 @ $0 · Tax withholding (F): 240 @ $275.64 · Sale (S): 750 @ $267.60 · Option exercise (M): 7,500 (derivative) @ $0 · +3 more | EDGAR |
| 2026-02-11 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 12,500 @ $63.55 · Sale (S): 2,000 @ $270.56 · Sale (S): 5,700 @ $271.66 · Sale (S): 2,824 @ $272.51 · Sale (S): 928 @ $273.71 · Sale (S): 552 @ $274.64 · +4 more | EDGAR |
| 2025-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 2,268 @ $176.39 · Sale (S): 750 @ $175.22 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 2,315 @ $179.25 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · +4 more | EDGAR |
| 2024-03-01 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 523 @ $63.55 · Sale (S): 523 @ $163.13 · Option exercise (M): 744 @ $63.55 · Sale (S): 744 @ $164.60 · Option exercise (M): 130 @ $63.55 · Sale (S): 130 @ $165.22 · +26 more | EDGAR |
| 2024-03-01 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 648 @ $63.55 · Sale (S): 648 @ $162.71 · Option exercise (M): 900 @ $63.55 · Sale (S): 900 @ $163.68 · Option exercise (M): 1,429 @ $63.55 · Sale (S): 1,429 @ $164.81 · +15 more | EDGAR |
| 2024-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 5,000 @ $52.26 · Sale (S): 5,000 @ $135 · Option exercise (M): 3,087 @ $52.26 · Sale (S): 3,087 @ $140 · Tax withholding (F): 1,533 @ $157 · Option exercise (M): 1,913 @ $52.26 · +3 more | EDGAR |
| 2024-01-24 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 2,500 @ $52.26 · Sale (S): 2,500 @ $130 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →